Akiram Therapeutics
Advancing radiotherapeutics to treat solid tumors
Akiram Therapeutics is active in the biotechnology, life science, precision medicine space based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2021.
As a business in biotechnology, life science, precision medicine, Akiram Therapeutics is listed here with the public details available about it.
The business is associated with European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Series_Unknown.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $67.9M in funding.
| Sector | Biotechnology, Life Science, Precision Medicine |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Country | SE |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $67,875,720 |
Website: akiramtherapeutics.se
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account